Discovery of Potent and Selective Leads Against Toxoplasma Gondii Dihydrofolate Reductase via Structure-Based Design

ACS Medicinal Chemistry Letters - United States
doi 10.1021/acsmedchemlett.6b00328
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Structure-Based Design of Potent and Selective CK1γ Inhibitors

ACS Medicinal Chemistry Letters
Organic ChemistryBiochemistryDrug Discovery
2012English

The MIC3 Gene of Toxoplasma Gondii Is a Novel Potent Vaccine Candidate Against Toxoplasmosis

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2003English

Toxoplasma Gondii Tachyzoite-Extract Acts as a Potent Immunomodulator Against Allergic Sensitization and Airway Inflammation

Scientific Reports
Multidisciplinary
2017English

Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors

ACS Medicinal Chemistry Letters
Organic ChemistryBiochemistryDrug Discovery
2015English

Dicyclic and Tricyclic Diaminopyrimidine Derivatives as Potent Inhibitors of Cryptosporidium Parvum Dihydrofolate Reductase: Structure-Activity and Structure-Selectivity Correlations

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2001English

Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors

2015English

Structure Based Design of Potent Selective Inhibitors of Protein Kinase D1 (PKD1)

English

Synthesis and Evaluation of Oryzalin Analogs Against Toxoplasma Gondii

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2010English

The Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii as Target for Structure-Based Drug Design

Parasitology
Animal ScienceZoologyParasitologyInfectious Diseases
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy